Jun 2, 2009
By:Jill Wechsler
Pharmaceutical Technology
Agency officials and manufacturers anticipate stricter enforcement of drug safety and quality.
 |
May 2, 2009
By:Jill Wechsler
Pharmaceutical Technology
Government funding is slated to boost comparative studies of prescription drugs.
|
Apr 2, 2009
By:Jill Wechsler
Pharmaceutical Technology
FDA is poised to gain authority and resources to ensure the quality of food and drugs.
|
Mar 2, 2009
By:Jill Wechsler
Pharmaceutical Technology
Broader disclosure of drug prices and conflicts of interest are central healthcare reform issues.
|
Feb 19, 2009
By:Jill Wechsler
Pharmaceutical Technology
The stimulus bill expands the healthcare safety net while boosting investment in health IT and comparative research.
|
Feb 2, 2009
By:Jill Wechsler
Pharmaceutical Technology
Efforts to cut healthcare outlays will focus on drug costs, despite a drop in prescription sales.
|
Jan 2, 2009
By:Jill Wechsler
Pharmaceutical Technology
Will more resources and new leadership fix FDA, or is a major overhaul in order?
|
Dec 2, 2008
By:Jill Wechsler
Pharmaceutical Technology
To expand coverage amidst the economic crisis, Obama will look for ways to cut healthcare costs.
|
Nov 2, 2008
By:Jill Wechsler
Pharmaceutical Technology
Policymakers weigh new rules to ensure the safety and quality of drugs made with tiny particles.
|
| 
